Crystagen.
About Crystagen
Crystagen is studied in tissue regeneration and repair research, including cell and animal models. One study on spleen aging reported that Crystagen activates B-cells without affecting cellular renewal in aging spleen tissue. A specific molecular mechanism is not independently confirmed.
Research Application
Discussed as a potential immune modulator in the context of immune aging. The data are very thin, concentrated in one research group, and do not support robust efficacy claims.
Important to know
Claims circulating online are often not backed by valid clinical data. Treat all information as a starting point for your own scientific research, not as usage guidance.
Sequence and regulatory status data are based on publicly available sources and refer to the compound in general, not to a specific product.
Research Overview
Studies on regenerative peptides are mostly derived from cell culture and animal models; comprehensive clinical data is typically still limited.
- Chervyakova NA, et al. Adv Gerontol. 2014;27(1):224–228. PMID 28976144
References without a PMID can be located via the respective publisher. This overview does not claim to be exhaustive.
Similar Peptides
Question about Crystagen?
We reply personally – via email or Telegram.